Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 1995;26:1003-1010

This Article
Right arrow Full Text
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Shibata, H.
Right arrow Articles by Saruta, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shibata, H.
Right arrow Articles by Saruta, T.

(Hypertension. 1995;26:1003-1010.)
© 1995 American Heart Association, Inc.


Articles

Gene Expression of Angiotensin II Receptor in Blood Cells of Cushing's Syndrome

Hirotaka Shibata; Hiromichi Suzuki; Tatsuya Maruyama; Takao Saruta

From the Department of Internal Medicine, School of Medicine, Keio University, Shinjuku-ku, Tokyo, Japan.

Correspondence to Takao Saruta, MD, PhD, Department of Internal Medicine, School of Medicine, Keio University, 35 Shinanomachi, Shinjuku-ku, Tokyo 160, Japan.

Abstract The relation between serum cortisol, plasma renin activity, angiotensin II (Ang II), or aldosterone levels and peripheral blood cell (mononuclear leukocytes and platelets) angiotensin II type 1A (AT1A) and 1B (AT1B) receptor mRNA levels was examined in both patients with Cushing's syndrome (seven patients with Cushing's syndrome due to unilateral adrenal cortical adenoma) and control subjects (seven normotensive patients with renal cell carcinoma). Blood was collected from each participant for estimation of plasma renin activity and plasma angiotensin II, aldosterone, and cortisol concentrations and for isolation of mononuclear leukocytes and platelets, which were then used to measure AT1A and AT1B receptor mRNA levels before and after adrenalectomy with the use of reverse transcription–polymerase chain reaction. In patients with Cushing's syndrome, both mononuclear leukocyte and platelet AT1A mRNA levels, which were elevated, were reduced after removal of the adrenal tumors, whereas AT1B receptor mRNA levels of both types of blood cells did not significantly change after adrenalectomy. In contrast, in control subjects, both AT1A and AT1B receptor mRNA levels did not significantly change after unilateral adrenalectomy and nephrectomy. In the adrenal tumors of patients with Cushing's syndrome, gene expression of AT1A receptor was decreased compared with that from adrenals of control subjects. AT1A receptors of the platelets were shown to be upregulated in a manner similar to those of mononuclear leukocytes in patients with Cushing's syndrome. These results suggest that cortisol excess is an important factor upregulating AT1A receptor mRNA levels in human blood cells.


Key Words: receptor, angiotensin II • Cushing's syndrome • glucocorticoid • RNA, messenger • adrenal glands • leukocyte, mononuclear • blood, platelet • blood cells




This article has been cited by other articles:


Home page
Circ. Res.Home page
Y. Zhou, Y. Chen, W. P. Dirksen, M. Morris, and M. Periasamy
AT1b Receptor Predominantly Mediates Contractions in Major Mouse Blood Vessels
Circ. Res., November 28, 2003; 93(11): 1089 - 1094.
[Abstract] [Full Text] [PDF]